# Faeth Therapeutics Inc. (FTH) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $40.05, market value $1.0 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Faeth Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 6.0×**. The shares trade at 6.0× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -3.3%** (5-yr avg -125.3%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -113.4%**. Return on equity is negative because earnings are negative.

## Growth
- **EPS growth (1 yr): 30.4%**. Earnings per share rose 30.4%.

## Financial health
- **Debt to equity: 0.03**. Debt is 0.03 times equity: a conservative balance sheet.
- **Current ratio: 5.06** (quick 5.06). Current assets cover the next year's liabilities 5.06 times.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Faeth Therapeutics Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (11 analysts). 11 analysts cover Faeth Therapeutics Inc.; the consensus is strong_buy, with an average price target of $54.64 (+36% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 354.4%** (YTD 275.4%, 3-mo 173.4%). The shares are up 354.4% over twelve months including dividends.
- **From 52-week high: -2.7%** (437.6% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 73**. An RSI of 73 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.97** (volatility 222%). Beta of 1.97 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=FTH · Page: https://foliofundamentals.com/stocks/fth

Not investment advice.